Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4172926
Max Phase: Preclinical
Molecular Formula: C57H96N12O12
Molecular Weight: 1141.47
Molecule Type: Small molecule
Associated Items:
ID: ALA4172926
Max Phase: Preclinical
Molecular Formula: C57H96N12O12
Molecular Weight: 1141.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C
Standard InChI: InChI=1S/C57H96N12O12/c1-30(2)25-41(62-37(13)70)51(75)60-35(11)49(73)64-43(27-32(5)6)53(77)63-40(17-14-15-23-58)50(74)67-45(29-38-19-21-39(71)22-20-38)55(79)66-44(28-33(7)8)54(78)65-42(26-31(3)4)52(76)61-36(12)57(81)69-24-16-18-46(69)56(80)68-47(34(9)10)48(59)72/h19-22,30-36,40-47,71H,14-18,23-29,58H2,1-13H3,(H2,59,72)(H,60,75)(H,61,76)(H,62,70)(H,63,77)(H,64,73)(H,65,78)(H,66,79)(H,67,74)(H,68,80)/t35-,36-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1
Standard InChI Key: YQKXZXWIEXDJMO-ZDFGDACUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1141.47 | Molecular Weight (Monoisotopic): 1140.7271 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):